MedTrace Logo

Clinical Study to Evaluate CryoBalloon™ Ablation System in Patients Undergoing Esophagectomy

NCT02729727 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2022-04-28

No results posted yet for this study

Summary

To evaluate the safety and treatment effect of the CryoBalloon™ Full Ablation System for the ablation of human esophageal epithelium in patients scheduled to undergo esophagectomy

Conditions

  • Esophageal Cancer

Interventions

DEVICE

CryoBalloon Ablation System

Tissue Ablation using CryoBalloon Ablation System

Sponsors & Collaborators

  • Pentax Medical

    lead INDUSTRY

Principal Investigators

  • Jacques J.G.H.M. Bergman, MD, PhD · AMC Medical Research B.V.

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-06-24
Completion
2016-06-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02729727 on ClinicalTrials.gov